Clinical Oncology Advisory Board


A forum of oncology leaders dedicated to advancing ethical, scientifically rigorous clinical research through practical guidance and shared learning.

Advarra’s Clinical Oncology Advisory Board (COAB) provides expert perspective on evolving oncology research challenges, from study design considerations to ethical and safety oversight.

Why we exist

How the COAB works

  • Focused discussions on timely issues in oncology clinical research. 
  • Action-oriented outputs intended for community use (publications and presentations). 
  • Practical considerations that support ethical decision-making and patient-centered safety oversight.

Members

Munveer Bhangoo, MD

Hematologist and oncologist
Scripps Health

Sayeh Lavasani, MD

Associate Clinical Professor, Division of Hematology Oncology
University of California, Irvine

Melody A. Cobleigh, MD

Director, Medical Oncology
Rush University Medical Center

Charles A. Schiffer, MD

Emeritus Professor of Oncology; former director, Leukemia/Lymphoma Multidisciplinary Program
Wayne State University School of Medicine and Karmanos Cancer Institute

David T. Curiel, MD, PhD

Professor, Cancer Biology Division, Department of Radiation Oncology
Emory University

The COAB is guided by three objectives:

Research strategy and guidance

The COAB provides perspective on study design considerations, execution challenges, patient population considerations, and the integration of emerging approaches, including precision medicine and immunotherapy.

Authorship and knowledge dissemination

TheCOAB supports the development of community-facing content—such as white papers, position statements, blogs, and conference materials—grounded in member expertise and discussion themes.

Patient-centered safety oversight

The COAB discussions emphasize ethical integrity and safety considerations that can help inform responsible oncology research practices.

Frequently asked questions

Login
Scroll to Top